Your browser doesn't support javascript.
[Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19].
Chulanov, V P; Bakirov, B A; Vezikova, N N; Gorodin, V N; Zhuravleva, M V; Zagrebneva, A I; Ivanov, I G; Lomakin, N V; Lukina, G V; Moysova, D L; Mutovina, Z I.
  • Chulanov VP; National Medical Research Center for Phthisiopulmonology and Infectious Diseases.
  • Bakirov BA; Bashkir State Medical University.
  • Vezikova NN; Petrozavodsk State University.
  • Gorodin VN; Kuban State Medical University.
  • Zhuravleva MV; Scientific Centre for Expert Evaluation of Medicinal Products.
  • Zagrebneva AI; City Clinical Hospital No. 52.
  • Ivanov IG; Pirogov Russian National Research Medical University.
  • Lomakin NV; City Hospital of St. George the Great Martyr.
  • Lukina GV; Saint Petersburg State University.
  • Moysova DL; Central Clinical Hospital with a Polyclinic of the Administrative Department of the President of the Russian Federation.
  • Mutovina ZI; Central State Medical Academy of the Administrative Department of the President of the Russian Federation.
Ter Arkh ; 94(8): 1028-1035, 2022 Oct 12.
Article in Russian | MEDLINE | ID: covidwho-2091506
ABSTRACT
The Advisory Board chaired by the chief specialist in infectious diseases of the Ministry of Health of Russian Federation, Professor V.P. Chulanov was held on June 18, 2022 in Saint Petersburg. Aim. The main purpose of the Board was following

discussion:

the analysis of the real-world data of levilimab as an anticipatory therapy for COVID-19 in hospitalized patients; the review of the experience and perspectives of levilimab as an anticipatory anti-inflammatory option for outpatient patients who meet defined clinical and laboratory criteria. Results. The analyzed data on clinical efficacy and safety formed the basis of recommendations proposed by experts for the use of levilimab in the inpatient and outpatient medical care for COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: Russian Journal: Ter Arkh Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: Russian Journal: Ter Arkh Year: 2022 Document Type: Article